Global Pharmaceutical Isolator Market, By Type (Aseptic Isolators, Containment Isolators, Bio Isolators, Sampling and Weighing Isolators, Active Pharmaceutical Ingredient (API) Manufacturing Isolators, Others), Product Class Type (ISO Class 5, Class III), System Type (Open System, Closed System), Pressure Difference (Positive Pressure, Negative Pressure), Configuration (Floor Standing, Mobile, Compact, Modular, Table Top, Portable), Application (Sterility Testing, Pharmaceutical Industry, Microbiology Safety Cabinets, Sampling/ Weighing/ Distribution, Animal Laboratories, Medical Device Manufacturing, Others), End-User (Pharmaceutical and Biotechnology Companies, Contract Research Organization, Academic and Research Institutes, Hospitals, Diagnostic Laboratories), Distribution Channel (Direct Tender, Retailer) – Industry Trends and Forecast to 2029
Market Analysis and Size
A pharmaceutical isolator is a device that isolates a pharmaceutical process or activity from the operator as well as the rest of the environment. This could generate a clean or classified aseptic environment to protect a function or activity from microbiological and nonviable contamination caused by the operator and the surrounding environment.
Data Bridge Market Research analyses that the pharmaceutical isolator market was USD 5,966.07 million in 2021, would rocket up to USD 10136.42 million by 2029, and is expected to undergo a CAGR of 6.85% during the forecast period of 2022 to 2029. The market report curated by the Data Bridge Market Research team includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Pharmaceutical isolators are used as a contamination-free barrier system in the pharmaceutical sector. Microbiological testing, cell therapy processing, advanced therapy medicinal product (ATMP) manufacturing, and the weighing, packing, and dispensing of injectable sterile goods are just a few of the applications for pharmaceutical isolators. The use of pharmaceutical isolators is being boosted by the continued growth of the pharmaceutical market in both developing and established countries and rising research and development expenditure to produce innovative treatments. The improved pharmaceutical isolators and the pharma industries' demands have prompted major manufacturers to grow their pharmaceutical isolator industry.
Report Scope and Market Segmentation
2022 to 2029
2020 (Customizable to 2019 - 2014)
Revenue in USD Million, Volumes in Units, Pricing in USD
By Type (Aseptic Isolators, Containment Isolators, Bio Isolators, Sampling and Weighing Isolators, Active Pharmaceutical Ingredient (API) Manufacturing Isolators, Others), Product Class Type (ISO Class 5, Class III), System Type (Open System, Closed System), Pressure Difference (Positive Pressure, Negative Pressure), Configuration (Floor Standing, Mobile, Compact, Modular, Table Top, Portable), Application (Sterility Testing, Pharmaceutical Industry, Microbiology Safety Cabinets, Sampling/ Weighing/ Distribution, Animal Laboratories, Medical Device Manufacturing, Others), End User (Pharmaceutical and Biotechnology Companies, Contract Research Organization, Academic and Research Institutes, Hospitals, Diagnostic Laboratories), Distribution Channel (Direct Tender, Retailer)
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
Market Players Covered
Amico Group of Companies (Canada), ArjoHuntleigh (Sweden), Famed Zywiec Sp.zo.o. (Poland), Getinge AB (Sweden), Hill Room Holding (USA), Invacare Corporation (USA), Malvestio Spa (Italy), Medline Industries Inc. (USA), Merivaara Corporation (Finland), Midmark Corporation (USA), Paramount Bed Co., Ltd. (Japan), and Span America Medical System Inc. (USA), Skan AG (Switzerland), Azbil (Spain), Robert Bosch GmbH (Germany), Hosokawa Micron Ltd. (U.K.), Schematic Engineering Industries (India), Gelman Singapore (Singapore), COMECER S.P.A. (Italy), Iso Tech Design (Canada), MBRAUN (Germany), NuAire Inc. (U.S.), VanRx Pharmasystems Inc. (Canada), Fedegari Autoclavi S.p.A (Italy), and LAF Technologies (Australia)
Pharmaceutical Isolator Market Dynamics
- Increasing use of sterilized procedures
The rising use of hazardous compounds, the increasing cost of non-compliance, and the rise in research laboratories are important drivers driving the pharmaceutical isolators market during the forecast period. The interior of a pharmaceutical isolator is kept isolated from the outside environment indefinitely. Pharmaceutical isolators are commonly used to handle drugs, quality control activities, and goods that must be completely isolated from the outside world.
The majority of pharmaceutical isolators are built to satisfy the needs of manufacturing or research institutions. Market expansion is fueled by increased strategic collaboration and a strict product approval process. Pharmaceutical isolators have minimal operating costs, another primary driver of market growth. Pharmaceutical companies may get isolators from reputable manufacturers for a fraction of the cost of standard clean rooms. The presence of an operator in a clean space that has been cleansed and disinfected can contaminate it. On the other hand, the pharmaceutical isolator industry minimizes contamination. It provides a bio-decontaminated environment where only the drug and production materials come into contact with the entire management system.
Furthermore, isolators for pharmaceutical applications are enabled by key advancements such as advanced mobility, enhanced coherence with active pharmaceutical ingredients or APIs, and a significant sterility guarantee. These factors have combined to boost the growth of the pharmaceutical isolators market.
Most experts disagree that regulatory entities are no longer inhibiting the development of breakthroughs like pharmaceutical isolators. The pharmaceutical industry's demand for containment solutions is consistent, but the food, cosmetics, and detergent industries are posing new obstacles.
This pharmaceutical isolator market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the pharmaceutical isolator market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
COVID-19 Impact on Pharmaceutical Isolator Market
The COVID-19 pandemic has emerged as the world's most serious threat. It has caused havoc in a variety of trades and enterprises all around the world. The pandemic, on the other hand, has given pharmaceutical and biopharmaceutical companies numerous opportunities to extend their research and development efforts in order to develop novel vaccines against the novel coronavirus. Corporations are conducting clinical trials in try to curb the spread of the COVID-19 virus. Pharmaceutical isolator providers for biopharmaceutical organisations will have greater opportunities as the number of clinical investigations grows.
Bioquell Inc (U.S.) was honoured in the Best Health Care and Pharmaceutical PLC category of the U.K. Stock Market awards in May 2018.
ENVAIR LTD. announced their participation at the ANALYTICA 2016 event in Germany in May 2016. Microbiological safety workbenches, PCR Thermal Cycler, and Centrifuge will be among the company's many goods on display. The company's growth will be aided by the display of their product range at an international trade expo for laboratory technology, analysis, and biotechnology.
Global Pharmaceutical Isolator Market Scope
The pharmaceutical isolator market is segmented based on type, product, application, system, pressure and end-user, and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
- Aseptic isolators
- Containment isolators
- Bio isolators
- Sampling and weighing isolators
- Active pharmaceutical ingredient (API) manufacturing isolators
On the basis of type, the market is segmented into aseptic isolators, containment isolators, bio isolators, sampling and weighing isolators, active pharmaceutical ingredient (API) manufacturing isolators and others
- Class III
- ISO Class 5
On the basis of product class type, the market is segmented into Class III and ISO Class 5.
- Closed system
- Open system
- Positive pressure
- Negative pressure
On the basis of pressure difference, the market is segmented into positive pressure and negative pressure
- Floor standing
- Table top and portable
On the basis of configuration, the market is segmented into floor standing, modular, mobile, compact, table top and portable
- Sterility testing
- Pharmaceutical industry
- Microbiology safety cabinets
- Sampling/ Weighing/ Distribution
- Animal laboratories
- Medical device manufacturing Others
On the basis of application, the market is segmented into sterility testing, pharmaceutical industry, microbiology safety cabinets, sampling/ weighing/ distribution, animal laboratories, medical device manufacturing and others.
- Diagnostic laboratories
- Academic and research institutes
- Pharmaceutical and biotechnology companies
- Contract research organization
On the basis of end-user, the market is segmented into hospitals, diagnostic laboratories, academic and research institutes, pharmaceutical and biotechnology companies and contract research organization.
- Direct tender
On the basis of distribution channel, the market is segmented into direct tender and retailer
Pharmaceutical isolator Market Regional Analysis/Insights
The pharmaceutical isolator market is analyzed and market size insights and trends are provided by country, type, price range, application and end-user as referenced above.
The countries covered in the pharmaceutical isolator market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
Because of the increasing use of innovative technology and investments in the healthcare sector, North America dominates the worldwide pharmaceutical isolator market. The growing number of healthcare providers and biotechnology laboratories additionally aids regional market expansion.
Due to the presence of notable and powerful competitors in the regional market, Europe is expected to experience significant growth.
Asia Pacific is also expected to grow knowingly with a high CAGR in the global pharmaceutical isolator market due to the growing investments in the pharmaceutical isolators.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
The pharmaceutical isolator market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for pharmaceutical isolator market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the pharmaceutical isolator market. The data is available for historic period 2010-2020.
Competitive Landscape and Pharmaceutical Isolator Market Share Analysis
The pharmaceutical isolator market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to pharmaceutical isolator market.
Some of the major players operating in the pharmaceutical isolator market are:
- Amico Group of Companies (Canada)
- ArjoHuntleigh (Sweden)
- Famed Zywiec Sp.zo.o. (Poland)
- Getinge AB (Sweden)
- Hill Room Holding (USA)
- Invacare Corporation (USA)
- Malvestio Spa (Italy)
- Medline Industries Inc. (USA)
- Merivaara Corporation (Finland)
- Midmark Corporation (USA)
- Paramount Bed Co., Ltd. (Japan)
- Span America Medical System Inc. (USA)
- Skan AG (Switzerland)
- Azbil (Spain)
- Robert Bosch GmbH (Germany)
- Hosokawa Micron Ltd. (U.K.)
- Schematic Engineering Industries (India)
- Gelman Singapore (Singapore)
- COMECER S.P.A. (Italy)
- Iso Tech Design (Canada)
- MBRAUN (Germany)
- NuAire Inc. (U.S.)
- VanRx Pharmasystems Inc. (Canada)
- Fedegari Autoclavi S.p.A (Italy)
- LAF Technologies (Australia)
Research Methodology: Global Pharmaceutical Isolator Market
Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analyzed and estimated using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please request an analyst call or can drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Factbook) or can assist you in creating presentations from the data sets available in the report.